Clinical trials: Hypomagnesemia
Gitelman Syndrome
Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics
Gitelman syndrome is a rare renal disease where the kidneys are unable to normally retain some salts (sodium, potassium and magnesium).
- Trial name
- GITAB (NCT01146197)
- Testing
- TREATMENT
- Where
- France
- Volunteers
- 33 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Intensive Care Unit Syndrome
Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD
It has been reported in several studies that ionized hypomagnesemia is associated with higher morbidity and mortality rates. During continuous renal replacement therapy with regional citrate anticoagulation (CRRT-RCA), the loss…
- Trial name
- MagiCC (NCT04412980)
- Where
- France
- Volunteers
- 40 people
- Sponsor
- University Hospital, Montpellier
Arrhythmia, Quality of Life
Magnesium to Reduce Implantable Cardioverter Defibrillator (ICD) Shocks and Improve Patient's Quality of Life.
This study is being conducted to see if magnesium can reduce the number of shocks patients with ICDs experience and to see if magnesium supplementation improves patients quality of life.
- Conditions
- Arrhythmia, Quality of Life, Hypomagnesemia
- Trial name
- NCT00282620
- Testing
- Magnesium L-lactate
- Where
- United States
- Volunteers
- 240 people
- Sponsor
- Hartford Hospital
Vascular Calcification, Chronic Kidney Disease
Serum Magnesium and Vascular Calcification
Both Kidney transplantation (KT) and Chronic Kidney Disease (CKD) patients have reduced kidney function. Low serum magnesium is more prevalent in KT recipients.
- Trial name
- NCT01293786
- Where
- Thailand
- Volunteers
- 400 people
- Sponsor
- Ramathibodi Hospital
Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis
National Registry of Rare Kidney Diseases
The goal of this National Registry is to is to collect information from patients with rare kidney diseases, so that it that can be used for research.
- Conditions
- Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis
- Trial name
- RaDaR (NCT06065852)
- Where
- United Kingdom
- Volunteers
- 35,000 people
- Sponsor
- UK Kidney Association
Osteoporosis, Hypomagnesemia
Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate
Proton pump inhibitors (PPIs) are widely used for the control of gastric ulcer-gastritis, erosive esophagitis (gastroesophageal reflux disease), peptic ulcer disease (duodenal ulcer), and heartburn.
- Trial name
- NCT03812380
- Testing
- EffCaMgCit
- Where
- United States
- Volunteers
- 62 people, healthy volunteers welcome
- Sponsor
- University of Texas Southwestern Medical Center
Chronic Kidney Disease, Hypomagnesemia
Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease
Randomized placebo-controlled interventional trial to investigate the effect of oral magnesium supplementation on intracellular magnesium in subjects with chronic kidney disease.
- Trial name
- NCT02216877
- Testing
- Mablet 360 mg
- Where
- Denmark
- Volunteers
- 36 people
- Sponsor
- Zealand University Hospital
Refeeding Syndrome
Risk Factors for Refeeding Syndrome in the Surgical Intensive Care Unit
Refeeding Syndrome is a condition that occurs when patients who are undernourished or undernourished suddenly start overfeeding, causing electrolyte disturbances and vitamin deficiencies, resulting in neurological and cardiac…
- Trial name
- NCT06054139
- Testing
- Refeeding Syndrome
- Where
- Turkey (Türkiye)
- Volunteers
- 60 people
- Sponsor
- Samsun University
Magnesium Deficiency
Preoperative Ionized Magnesium Assessment
The reported incidence of hypomagnesemia is approximately 2% in the general population. Hypomagnesemia is a common problem, occurring in nearly 10%of general hospitalized patients and 17% of hospitalized cancer patients.
- Trial name
- NCT04972344
- Testing
- Ionized magnesium
- Where
- South Korea
- Volunteers
- 536 people
- Sponsor
- Seoul National University Bundang Hospital
Hypomagnesemia, Intestinal, With Secondary Hypocalcemia, Drug Induced Hypomagnesemia
Prevalence and Intervention of Hypomagnesemia in Users of Proton-pump Inhibitors
Hypomagnesemia is a severe side effect of longterm use of all available proton-pump inhibitors (PPIH). It develops due to intestinal malabsorption of Mg2+.
- Trial name
- Privet (NCT02518659)
- Testing
- Inulin
- Volunteers
- 21 people, healthy volunteers welcome
- Sponsor
- Radboud University Medical Center
Diabetic Nephropathies
Hypomagnesemia and Diabetic Nephropathy
To find if there is a corrolatation between Microalbuminurea and diabetic retinopathy, in daibetic patients
- Trial name
- NCT03690180
- Testing
- serum magnesium
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Fayoum University
Hypomagnesemia
Dynamic Magnesium Replacement Strategies and 28-Day Mortality in Non-Cardiac Critically Ill Patients With Hypomagnesemia: A Target Trial Emulation
This study looks at how different ways of giving magnesium (a nutrient) affect the risk of death within 28 days for adults with low magnesium levels who are in the intensive care unit (ICU) for non-heart-related reasons.
- Trial name
- NCT07380542
- Where
- China
- Volunteers
- 12,887 people
- Sponsor
- Fujian Provincial Hospital
Hypomagnesemia
The Study of Urinary Biomarkers in Patients With Hypomagnesemia
In this pilot exploratory study, we aim to examine extracellular vesicles (EVs) as biomarkers in urine from up to 15 patients, with up to 10 samples per patient among the patients with a history of hypomagnesemia.
- Trial name
- NCT07056283
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- University of Florida
Sarcopenia
Magnesium Supplementation as a Nutritional Intervention in Sarcopenia
Sarcopenia is a progressive condition common in older adults and is characterized by loss of muscle strength, muscle mass, and physical performance.
- Trial name
- SARCOMAG (NCT07567963)
- Testing
- Citrate Magnesium Supplementation
- Where
- Portugal
- Volunteers
- 352 people, healthy volunteers welcome
- Sponsor
- Escola Superior de Saúde - Universidade do Algarve
Osteoporosis, Hypomagnesemia
EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy
Proton pump inhibitors (PPIs) are widely used for the control of gastric ulcer-gastritis, erosive esophagitis (gastroesophageal reflux disease), peptic ulcer disease (duodenal ulcer), and heartburn.
- Trial name
- NCT05998863
- Testing
- EffCaMgCit
- Where
- 2 sites in United States
- Volunteers
- healthy volunteers welcome
- Sponsor
- University of Texas Southwestern Medical Center
Renal Failure Chronic Requiring Dialysis, Diabetes Mellitus, with Complications
Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation
Magnesium is essential in human physiology. Simultaneous pancreas-kidney (SPK) transplant recipients frequently experience hypomagnesemia. The effects of hypomagnesaemia are harmful.
- Conditions
- Renal Failure Chronic Requiring Dialysis, Diabetes Mellitus, with Complications, Glomerulosclerosis, Pancreatic Insufficiency (Exocrine and Endocrine)
- Trial name
- NCT06766786
- Testing
- Magnesium Sulfate high dose
- Where
- United Kingdom
- Volunteers
- 40 people
- Sponsor
- Dr Olu Bamgbade, MD, FRCPC
Hypomagnesemia, Hypocalcemia
Hypomagnesemia and Hypocalcemia Association Following Thyroidectomy
Magnesium plays a role in the active transport of calcium (Ca+2) and potassium ions across cell membranes. Most of it is intracellular or in the bone , however less than 1% of magnesium is in the blood serum.
- Conditions
- Hypomagnesemia, Hypocalcemia, Hypomagnesemia With Secondary Hypocalcemia
- Trial name
- NCT04351451
- Testing
- thyroidectomy
- Where
- Saudi Arabia
- Volunteers
- 74 people
- Sponsor
- King Saud University